Teladoc Health, Inc. (NYSE:TDOC) Given Average Rating of “Hold” by Brokerages

Shares of Teladoc Health, Inc. (NYSE:TDOC) have been assigned a consensus recommendation of “Hold” from the seventeen analysts that are presently covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, eleven have issued a hold rating and five have assigned a buy rating to the company. The average twelve-month target price among brokers that have issued a report on the stock in the last year is $7.4333.

A number of equities analysts have issued reports on TDOC shares. Leerink Partners reduced their price target on shares of Teladoc Health from $8.50 to $5.50 and set a “market perform” rating for the company in a research report on Thursday, February 26th. Weiss Ratings raised shares of Teladoc Health from a “sell (e+)” rating to a “sell (d-)” rating in a report on Friday, May 22nd. Deutsche Bank Aktiengesellschaft raised shares of Teladoc Health from a “hold” rating to a “buy” rating and set a $11.00 target price for the company in a report on Tuesday, March 10th. BMO Capital Markets dropped their target price on shares of Teladoc Health from $8.00 to $5.00 and set a “market perform” rating for the company in a report on Thursday, February 26th. Finally, Wells Fargo & Company dropped their price objective on shares of Teladoc Health from $8.00 to $6.00 and set an “equal weight” rating for the company in a report on Thursday, February 26th.

Insider Activity

In related news, insider Carlos Nueno sold 6,196 shares of the company’s stock in a transaction dated Tuesday, June 2nd. The shares were sold at an average price of $7.63, for a total value of $47,275.48. Following the completion of the sale, the insider owned 57,671 shares of the company’s stock, valued at approximately $440,029.73. This represents a 9.70% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Charles Divita III sold 19,132 shares of the company’s stock in a transaction dated Tuesday, June 2nd. The shares were sold at an average price of $7.63, for a total transaction of $145,977.16. Following the completion of the sale, the chief executive officer directly owned 389,894 shares of the company’s stock, valued at $2,974,891.22. This represents a 4.68% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last three months, insiders sold 39,870 shares of company stock worth $302,507. Company insiders own 0.70% of the company’s stock.

Institutional Investors Weigh In On Teladoc Health

A number of hedge funds have recently modified their holdings of the company. Essential Partners LLC acquired a new position in Teladoc Health in the first quarter valued at about $113,000. Janus Henderson Group PLC lifted its position in Teladoc Health by 7.7% in the first quarter. Janus Henderson Group PLC now owns 262,215 shares of the health services provider’s stock valued at $1,429,000 after buying an additional 18,679 shares during the last quarter. EverSource Wealth Advisors LLC lifted its position in Teladoc Health by 694.5% in the first quarter. EverSource Wealth Advisors LLC now owns 5,657 shares of the health services provider’s stock valued at $31,000 after buying an additional 4,945 shares during the last quarter. California State Teachers Retirement System lifted its position in Teladoc Health by 61.2% in the first quarter. California State Teachers Retirement System now owns 274,441 shares of the health services provider’s stock valued at $1,496,000 after buying an additional 104,160 shares during the last quarter. Finally, Quantinno Capital Management LP lifted its position in Teladoc Health by 128.0% in the first quarter. Quantinno Capital Management LP now owns 2,621,378 shares of the health services provider’s stock valued at $14,287,000 after buying an additional 1,471,631 shares during the last quarter. Hedge funds and other institutional investors own 76.82% of the company’s stock.

Teladoc Health Stock Up 2.4%

NYSE:TDOC opened at $7.10 on Thursday. The company’s 50-day simple moving average is $6.30 and its 200-day simple moving average is $6.22. The stock has a market capitalization of $1.28 billion, a P/E ratio of -7.32 and a beta of 2.14. The company has a debt-to-equity ratio of 0.75, a quick ratio of 2.72 and a current ratio of 2.80. Teladoc Health has a fifty-two week low of $4.40 and a fifty-two week high of $9.77.

Teladoc Health (NYSE:TDOC) last released its earnings results on Wednesday, April 29th. The health services provider reported ($0.36) EPS for the quarter, missing analysts’ consensus estimates of ($0.35) by ($0.01). The company had revenue of $613.85 million during the quarter, compared to analyst estimates of $611.04 million. Teladoc Health had a negative return on equity of 11.45% and a negative net margin of 6.81%.The firm’s revenue for the quarter was down 2.5% on a year-over-year basis. During the same quarter last year, the business earned ($0.53) earnings per share. Teladoc Health has set its FY 2026 guidance at -1.050–0.750 EPS and its Q2 2026 guidance at -0.300–0.200 EPS. On average, equities analysts anticipate that Teladoc Health will post -0.92 earnings per share for the current fiscal year.

Teladoc Health Company Profile

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.